|1.||Blobe, Gerard C: 13 articles (07/2014 - 01/2007)|
|2.||How, Tam: 6 articles (02/2009 - 01/2007)|
|3.||Stenvers, Kaye L: 5 articles (11/2014 - 04/2009)|
|4.||Bilandzic, Maree: 5 articles (11/2014 - 04/2009)|
|5.||Hempel, Nadine: 5 articles (02/2010 - 01/2007)|
|6.||Wang, Yao: 4 articles (11/2014 - 11/2007)|
|7.||Findlay, Jock K: 4 articles (11/2014 - 11/2007)|
|8.||Mythreye, Karthikeyan: 4 articles (11/2013 - 05/2009)|
|9.||Dong, Mei: 4 articles (05/2008 - 01/2007)|
|10.||Lei, Zhe: 3 articles (11/2013 - 05/2010)|
04/01/2009 - "The objective of this study was to determine whether human GCTs exhibit betaglycan expression and, if so, what impact this receptor has on tumor biology. "
04/01/2009 - "Previous studies have suggested that betaglycan acts as a tumor suppressor in certain human epithelial cancers. "
09/01/2014 - "We report, for the first time, the presence of TGFBR3 and/or MGEA5 rearrangements in tumors showing mixed features of HFLT and PHAT. "
09/01/2014 - "TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms."
11/01/2013 - "Reduced expression of TGFBR3 has been frequently observed in several types of human cancers. "
04/01/2014 - "Fibrous zones in adhesions were simultaneous to the presence of TGF-β1 and the membrane-bound form of betaglycan (7-d adhesions), whereas soluble betaglycan appeared in TGF-β1-positive areas showing limited fibrosis (3-d adhesions). "
08/01/2015 - "Simvastatin prevented fibrosis following MI, improved heart ultrastructure and function, up-regulated TGFBR3 and decreased ERK1/2 and JNK phosphorylation. "
08/01/2015 - "We examined the role of the TGF-β receptor III (TGFBR3) in the inhibition of cardiac fibrosis by simvastatin. "
05/11/2007 - "Transforming growth factor-beta1 (TGF-beta1) and BMP-7 (bone morphogenetic protein-7; OP-1) play central, antagonistic roles in kidney fibrosis, a setting in which the expression of endoglin (CD105), an accessory TGF-beta type III receptor, is increased. "
08/01/2015 - "TGFBR3 mediated the decreased cardiac fibrosis, collagen deposition and fibroblast activity, induced by simvastatin, following MI. "
07/01/2014 - "Evaluation of neuroblastoma patient microarray data revealed an association between TGFBR3, GPC1, and SDC3 expression and improved prognosis. "
03/01/2000 - "Conversely, TGF-beta type III receptor gene expression, which is required for an efficacious TGF-beta binding and function, is strongly reduced exclusively in neuroblastomas of stages 3 and 4. These findings were directly confirmed by immunohistochemical analyses of ten neuroblastoma specimens. "
11/01/2013 - "Comparison of mRNA from benign neuroblastic tumors and neuroblastomas revealed that expression of the type III TGF-β receptor (TGFBR3) decreases with advancing stage of neuroblastoma and this loss correlates with a poorer prognosis. "
01/01/2011 - "TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence."
02/01/2000 - "The nucleotide sequence of a protective recombinant antigen of Taenia crassiceps cysticerci present in all stages of Taenia solium (KETc7), cloned into pcDNA3 plasmid with the signal peptide sequence of the beta-glycan receptor (pTc-sp7), has been shown to be effective in protecting mice against experimental infection of T. "
|5.||Breast Neoplasms (Breast Cancer)
10/03/1997 - "In this study, we report that human breast cancer cell lines express reduced amounts of TGF-beta type III receptor (RIII) when compared with untransformed human mammary epithelial cells. "
03/01/2014 - "BMP2, BMP4, RUNX1, and TGFBR3 were significantly associated with breast cancer survival overall (P ARTP = 0.04, 0.02, 0.002, and 0.04, respectively). "
09/01/2013 - "Type III TGF-β receptor (TGFBR3) and its shed extracellular domain (sTGFBR3) regulate TGF-β signaling and maintain epithelial homeostasis, with loss of TGFBR3 expression promoting progression early in breast cancer development. "
10/03/1997 - "Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells."
08/15/2002 - "Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft."
|1.||Protein Sorting Signals (Signal Peptide)
|4.||Transforming Growth Factor beta (TGF-beta)
|5.||Messenger RNA (mRNA)
|8.||Transforming Growth Factors (Transforming Growth Factor)
|2.||Heterologous Transplantation (Xenotransplantation)